Under a proposed ballot initiative in California, billionaires would face a one-time 5% levy to cover funding shortages for health care, food assistance and education.
The acquisition is centered on Dark Blue Therapeutics’ small-molecule degrader of the MLLT1 and MLLT3 proteins, which is being tested for acute myeloid leukemia.
From biotech veterans to embattled modalities to a new wave of RNAi therapeutics, BioSpace’s NextGen Class of 2026 emerged during a tough fundraising environment in 2025. Check out the 15 battle-tested companies that caught our eye.
Corporate performance management solutions provider OneStream has entered into a definitive agreement to be acquired by Hg Capital, a technology investment firm.